Patients Stopping Weight-Loss Injections Put On Pounds at a Quadrupled Rate Than Dieters

A recent study indicates that people who come off new slimming jabs like Mounjaro or Wegovy may regain shed pounds at a significantly accelerated pace than those who stop traditional diet and exercise plans.

Research printed in a prominent medical journal demonstrates that while obese people often shed a large proportion of their body weight while using the jabs, the weight comes back at an average rate of 0.8 kg per month once they quit.

"Individuals using these medications need to be cognizant of the danger of quick rebound weight gain when the medication ends," warns researcher Dr. Susan Jebb.

That rate of recovery implies a reversion to original weight within about 18 months.

Comparing Treatments

The study, which examined 37 of trials involving over 9,000 of patients, contrasted the outcomes of GLP-1 agonists with conventional dieting.

The team emphasize that people who shed pounds through diet and exercise generally experience a slower creep back—around 100 grams monthly—once they finish.

Understanding the Quick Rebound

Experts believe the way of the injections accounts for the amplified rebound.

GLP-1 drugs imitate a natural hormone called GLP-1, which moderates hunger.

"Artificially providing the hormone concentrations several times higher than normal may cause the system to produce less of its own natural hormone, and could reduce sensitivity to its effects," noted Dr. Adam Collins, a nutrition specialist.

"Discontinuation of this medication results in appetite is no longer kept in check, making excessive eating much more probable."

A Chronic Disease?

Medical guidelines recommend the injections for people with obesity-related medical conditions, accompanied by recommended lifestyle changes.

Many experts contend that, due to the high risk of weight regain, the treatment should be considered life-long.

This perspective is reinforced by drug manufacturers, who say that the findings "emphasize the chronic nature of obesity," similar to managing conditions like high blood pressure.

User Experiences

People who have come off the medication report a intense resurgence of cravings.

"It felt as if a switch that goes on and you're instantly extremely hungry," recalled an individual.

This challenge is compounded if patients have not established lasting dietary or behavioural modifications during treatment.

Widespread Interest

Recent estimates indicate that millions of people in the UK have tried weight-loss jabs in the past year, with interest continuing to grow.

• Adoption is higher among females compared to males.
• The middle-aged demographic shows the greatest usage rates.
• Many obtain the medications through private prescriptions rather than public health services.

Ultimately, experts stress that while the jabs are potent agents for shedding pounds, they are not a standalone cure and long-term success hinges on combined behavioural management.